Inventor

CAI XIONG

US77 patents

⚠️ This page may combine multiple inventors who share the name “CAI XIONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CAI XIONG

CURIS INC

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Quinazoline based EGFR inhibitors containing a zinc binding moiety

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Quinazoline based EGFR inhibitors

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Fused amino pyridine as HSP90 inhibitors

Tyrosine kinase inhibitors containing a zinc binding moiety

Quinazoline based EGFR inhibitors

Quinazoline based EGFR inhibitors containing a zinc binding moiety

Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety

Quinazoline based EGFR inhibitors

Substituted 2-indolinone as PTK inhibitors containing a zinc binding moiety

Tyrosine kinase inhibitors containing a zinc binding moiety

Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Fused amino pyridine as HSP90 inhibitors

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

CYTOMED INC

Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders

Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Compounds and methods for the treatment of inflammatory and immune disorders

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

UCB SA

Muscarinic agonists and antagonists

Muscarinic agonists and antagonists

Compounds and methods for treatment of asthma, allergy and inflammatory disorders

Musarinic agonists and antagonists

Compounds and methods for treatment of asthma, allergy and inflammatory disorders

Muscarinic agonists and antagonists

Muscarinic agonists and antagonists

CAI XIONG

Phosphoinositide 3-kinase inhibitors with a zinc binding moiety

Phosphoinositide 3-kinase inhibitor with a zinc binding moiety

Fused amino pyridine as HSP90 inhibitors

Fused amino pyridine as HSP90 inhibitors

QIAN CHANGGENG

CDK inhibitors containing a zinc binding moiety

Quinazoline based EGFR inhibitors containing a zinc binding moiety